Aducanumab: Biogen Is The Latest Firm To Preempt A Negative EU Opinion On Approval

 
• By Ian Schofield
  
Pills with euro union flag, medicine
The CHMP can OK or reject EU drug approval applications • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography